Cso
CurrentMarvel uses a "drug redevelopment" approach to drug development. Marvel develops new synthetic chemical derivatives of an approved drug but for a new disease indication. Patent protection is sought as the new potential asset is developed by the Company. The Company believes the business model results in significantly less risk, cost and time to develop its.